Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis ; volume:13 ; number:1 ; day:25 ; month:3 ; year:2012 ; pages:1-10 ; date:12.2012
BMC nephrology ; 13, Heft 1 (25.3.2012), 1-10, 12.2012
- Creator
-
Takiue, Keiichi
- Contributor
-
Sugiyama, Hitoshi
Inoue, Tatsuyuki
Morinaga, Hiroshi
Kikumoto, Yoko
Kitagawa, Masashi
Kitamura, Shinji
Maeshima, Yohei
Wang, Da-Hong
Masuoka, Noriyoshi
Ogino, Keiki
Makino, Hirofumi
SpringerLink (Online service)
- DOI
-
10.1186/1471-2369-13-14
- URN
-
urn:nbn:de:1111-2016081220991
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Takiue, Keiichi
- Sugiyama, Hitoshi
- Inoue, Tatsuyuki
- Morinaga, Hiroshi
- Kikumoto, Yoko
- Kitagawa, Masashi
- Kitamura, Shinji
- Maeshima, Yohei
- Wang, Da-Hong
- Masuoka, Noriyoshi
- Ogino, Keiki
- Makino, Hirofumi
- SpringerLink (Online service)
Other Objects (12)
Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
Albuminuria
Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid
Putting it mildly
Publisher Correction: Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
De albuminuria
De albuminuria
Klinische Erfahrungen mit Adriamycin
Ergebnisse der Adriamycin-Therapie
Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
Albuminuria
Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid
Putting it mildly
Publisher Correction: Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
De albuminuria
De albuminuria
Klinische Erfahrungen mit Adriamycin
Ergebnisse der Adriamycin-Therapie
Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
Albuminuria
Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid
Putting it mildly
Publisher Correction: Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
De albuminuria
De albuminuria
Klinische Erfahrungen mit Adriamycin